Erschienen in:
01.04.2014 | Review Article
Causes and consequences of lipoprotein(a) abnormalities in kidney disease
verfasst von:
Florian Kronenberg
Erschienen in:
Clinical and Experimental Nephrology
|
Ausgabe 2/2014
Einloggen, um Zugang zu erhalten
Abstract
Lipoprotein(a) is one of the strongest genetically determined risk factors for cardiovascular disease, and patients with chronic kidney disease have major disturbances in lipoprotein(a) metabolism. Concentrations are increased and are influenced by glomerular filtration rate (GFR) and the amount of proteinuria. The reason for this elevation can be increased synthesis, as is the case for patients with nephrotic syndrome or those treated by peritoneal dialysis. In hemodialysis patients, a catabolic block is the reason for this elevation. The elevated concentrations might contribute to the tremendous cardiovascular risk in this particular population. In particular, the genetically determined small apolipoprotein(a) isoforms are associated with an increased risk for cardiovascular events and total mortality.